Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Non-Current Assets (2016 - 2025)

Marimed (MRMD) has disclosed Non-Current Assets for 13 consecutive years, with $145.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 6.73% to $145.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $596.2 million, a 1.06% decrease, with the full-year FY2024 number at $153.5 million, up 6.07% from a year prior.
  • Non-Current Assets was $145.5 million for Q3 2025 at Marimed, down from $147.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $156.0 million in Q3 2024 to a low of $58.3 million in Q1 2021.
  • A 5-year average of $119.0 million and a median of $131.5 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: soared 62.13% in 2022, then decreased 6.73% in 2025.
  • Marimed's Non-Current Assets stood at $78.6 million in 2021, then surged by 37.49% to $108.1 million in 2022, then soared by 33.9% to $144.7 million in 2023, then grew by 6.07% to $153.5 million in 2024, then decreased by 5.2% to $145.5 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Non-Current Assets are $145.5 million (Q3 2025), $147.2 million (Q2 2025), and $150.0 million (Q1 2025).